Clinical trial
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
NCT00008216 · Columbia University, Other · Terminated
Key facts
| NCT number | NCT00008216 |
|---|---|
| Title | Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer |
| Official title | The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Observational [Patient Registry] |
| Conditions | Adult Langerhans Cell Histiocytosis, Childhood Langerhans Cell Histiocytosis, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Procedure |
| Interventions | Peripheral Blood Stem Cell Transplantation |
| Enrollment | 48 |
| Start date | Jul 1, 1996 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: